Message from the SVP

Dear Friends,

Greenwich Hospital has much to be grateful for. I know many in our community are sharing their thanks and well wishes as Greenwich Hospital President Diane Kelly prepares to retire, culminating a healthcare career that spans four decades. When Diane took the helm at Greenwich Hospital in 2020, we were in the midst of a global pandemic. Despite facing historic challenges, she never lost sight of the vision to move our hospital forward. Through her leadership, we have realized advanced care in key clinical areas benefiting our community and patients for generations to come. I am delighted to share some of the most recent progress below.

Heart and Vascular: New Procedure for Abnormal Heart Rhythms | Greenwich Hospital is one of the first hospitals in the region to perform pulsed field ablation to treat atrial fibrillation (AFib). This technology, recently approved by the FDA, delivers nearly nonthermal energy to remodel cardiac tissue that causes abnormal heart rhythms. This novel and highly precise technique offers advances over current thermal approaches to safely and effectively treat AFib with faster procedure times and lower complication rates than conventional methods. Joseph Akar, MD, Chief of Cardiac Electrophysiology, Director of the Complex Ablation Program and Professor at the Yale School of Medicine, is the lead physician in Greenwich performing this innovative procedure.

Oncology: Leading with Precision | A warm welcome to William K. Oh, MD, who has been appointed as Medical Director of Smilow Cancer Hospital at Greenwich Hospital, as well as Director of Precision Medicine for Yale Cancer Center and Smilow Cancer Hospital. Dr. Oh will serve as the oncology service line leader and regional physician leader for lower Fairfield and Westchester Counties. In Greenwich, he will continue to develop integrated oncology care teams and expand the impact of multidisciplinary cancer care in our region.

Dr. Oh is a genitourinary oncologist with decades of experience caring for patients with prostate cancer. Prior to his new position, he served as the Chief Medical Officer and Executive Vice President of the Prostate Cancer Foundation and Chief Medical Officer of Sema4, a publicly-traded genomics and health intelligence company. He was System Chief of Hematology and Medical Oncology at Mount Sinai Health System as well as Deputy Director of the Tisch Cancer Institute. He was an Associate Professor of Medicine at Harvard Medical School and Clinical Director of the Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute.

Dr. Oh is committed to increasing the routine use of molecular and genetic testing for all patients with cancer, a goal he has been dedicated to throughout his career.

Emergency Department: Expanded Trauma Care | Greenwich Hospital’s Emergency Department has managed more than 42,000 visits this year, with nearly 1,000 patients requiring specialized care through our newly designated Level III Trauma Center. The designation by the American College of Surgeons enables our clinicians to provide a higher level of trauma capacity and emergency operations, administering prompt assessment, resuscitation, surgery, intensive care and stabilization of injured patients.

Philanthropy is making possible the extraordinary care we are providing at Greenwich Hospital. Please contact me to discuss opportunities to support our work. Thank you to our many devoted friends who inspire all of us at Greenwich Hospital to bring the highest level of health care to the communities we serve.

With much gratitude,

Noël Appel
Senior Vice President and Chief Development Officer
Greenwich Hospital Office of Development
203-863-3861
Noel.Appel@greenwichhospital.org